New method provides a more accurate way to predict dementia up to nine years before diagnosis

MADRID — BioN­Tech is back with new da­ta to sup­port its BNT211 pro­gram in sol­id tu­mors af­ter a man­u­fac­tur­ing tweak. The com­pa­ny is now re­view­ing

Dexamethasone treatment failed to demonstrate noninferiority to surgery for chronic subdural hematoma and was associated with more complications and a greater risk of later surgery,